References
- Bauer, P., and Kieser, M. (1999), “Combining Different Phases in the Development of Medical Treatments Within a Single Trial,” Statistics in Medicine, 18, 1833–1848.
- Beckman, R. A., Antonijevic, Z., Kalamegham, R., and Chen, C. (2016), “Adaptive Design for a Confirmatory Basket Trial in Multiple Tumor Types Based on a Putative Predictive Biomarker,” Clinical Pharmacology & Therapeutics, accepted.
- Chen, C., and Beckman, R. A. (2009), “Hypothesis Testing in a Confirmatory Phase III Trial with a Possible Subset Effect,” Statistics in Biopharmaceutical Research, 1, 431–440.
- Demetri, G., Becker, R., Woodcock, J., Doroshow, J., Nisen, P, and Sommer, J. (2011), “Alternative Trial Designs Based on Tumor Genetics/pathway Characteristics Instead of Histology,” Issue Brief: Conference on Clinical Cancer Research, Washington DC.
- Genz, A., Bretz, F., Miwa, T., Mi, X., Leisch, F., Scheipl, F., Bornkamp, B., Maechler, M., and Hothorn, T. (2015), “Multivariate Normal and t Distributions,” available at https://cran.r-project.org/web/packages/mvtnorm/mvtnorm.pdf
- Heinrich, M. C., Joensuu, H., Demetri, G. D.; Corless, C. L., Apperley, J., Fletcher, J. A., et al. (2008), “Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to be Associated with Imatinib-Sensitive Tyrosine Kinases,” Clinical Cancer Research., 14, 2717–2725.
- Jenkins, M., Stone, A., and Jennison, C. (2010), “An Adaptive Seamless Phase II/III Design for Oncology Trials with Subpopulation Selection Using Correlated Survival Endpoints,” Pharmaceutical Statistics, 10, 347–356.
- Jennison, C., and Turnbull, B. W (2000), Group Sequential Methods with Applications to Clinical Trials, Boca Raton, FL: Chapman & Hall.
- Lan, K., and DeMets, D. (1983), “Discrete Sequential Boundaries for Clinical Trials,” Biometrika, 70, 659–663.
- Magnusson, B. P., and Turnbull, B. W. (2013), “Group Sequential Enrichment Design Incorporating Subgroup Selection,” Statistical in Medicine, 32, 2695–2714.
- Posch, M., Koenig, F., Branson, M., Brannath, W., Dunger-Baldauf, C., and Bauer, P. (2005), “Testing and Estimation in Flexible Group Sequential Designs with Adaptive Treatment Selection,” Statistics in Medicine, 24, 3697–3714.
- Stallard, N., and Todd, S. (2003), “Sequential Designs for Phase III Clinical Trials Incorporating Treatment Selection,” Statistical in Medicine, 22, 689–703.
- Wang, S. J., Hung, H. J., and O'Neill, R. T. (2009), “Adaptive Patient Enrichment Designs in Therapeutic Trials,” Biometrical Journal, 51, 358–374.
- Wang, S. J., O'Neill, R. T., and Hung, H. J. (2007), “Approaches to Evaluation of Treatment Effect in Randomized Clinical Trials with Genomic Subset,” Pharmaceutical Statistics, 6, 227–244.